4//SEC Filing
Teehan Brendan 4
Accession 0001396814-25-000030
CIK 0001396814other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 6:25 PM ET
Size
7.7 KB
Accession
0001396814-25-000030
Insider Transaction Report
Form 4
Teehan Brendan
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-04$26.59/sh+99,500$2,645,705→ 99,500 totalExercise: $26.59Exp: 2036-02-04→ Common Stock (99,500 underlying) - Award
Common Stock
2025-02-01+54,000→ 54,000 total
Footnotes (2)
- [F1]Represents restricted stock units that vest in four equal annual installments beginning on February 1, 2026, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
- [F2]The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.
Documents
Issuer
Pacira BioSciences, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001891900
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 6:25 PM ET
- Size
- 7.7 KB